Fecal Calprotectin in Healthy Children Aged 1-4 Years

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Zhu, Qingling ^a   Li, Feng ^a   Wang, Junli ^a   Shen, Lixiao ^a   Sheng, Xiaoyang ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH LENGTH; BIRTH WEIGHT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; LENGTH FOR AGE Z SCORE; MALE; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; WEIGHT FO LENGTH Z SCORE; WEIGHT FOR AGE Z SCORE; CHEMISTRY; FECES; INFANT; PRESCHOOL CHILD;

CHILD, PRESCHOOL; FECES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 84962274919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150725     Document Type: Article

References (35)

1. Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem. 1983; 134(1):1-6. PMID: 6861753.
2. Berntzen HB, Fagerhol MK. L1, a major granulocyte protein; isolation of high quantities of its subunits. Scand J Clin Lab Invest. 1990; 50(7):769-74. PMID: 2293338.
3. Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985; 84(1):24-34. PMID: 2409791.
4. Manolakis AC, Kapsoritakis AN, Tiaka EK, Potamianos SP. Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci. 2011; 56(6):1601-11.doi: 10.1007/s10620-010-1494-9 PMID: 21203903.
5. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990; 336(8718):763-5. PMID: 1976144.
6. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992; 27(9):793-8. PMID: 1411288.
7. Herting E, Stichtenoth G, Robertson B. Syringes with rubber-coated plungers and inactivation of surfactant. Lancet. 2003; 361(9354):311-.doi: 10.1016/s0140-6736(03)12334-3 PMID: 12559869.
8. Fagerhol MK. Nomenclature for proteins: Is calprotectin a proper name for the elusive myelomonocytic protein? Clin Mol Pathol. 1996; 49(2):M74-9. PMID: 16696054
9. Roseth AG. Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis. 2003; 35(9):607-9. PMID: 14563180.
10. Naess-Andresen CF, Egelandsdal B, Fagerhol MK. Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein). Clin Mol Pathol. 1995; 48(5):M278-84. PMID: 16696022.
11. Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, et al. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol. 2000; 95(10):2831-7.doi: 10.1111/j.1572-0241.2000.03194.x PMID: 11051356.
12. Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther. 2004; 20(6):615-21.doi: 10.1111/j.1365-2036.2004.02128.x PMID: 15352909.
13. Garcia Sanchez Mdel V, Gonzalez R, Iglesias Flores E, Gomez Camacho F, Casais Juanena L, Cerezo Ruiz A, et al. Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy. Med Clin (Barc). 2006; 127(2):41-6. PMID: 16801001.
14. Canani RB, De Horatio LT, Terrin G, Romano MT, Miele E, Staiano A, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2006; 42(1):9-15. PMID: 16385247.
15. Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001; 33(1):14-22. PMID: 11479402.
16. Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005; 40 (4):450-5. PMID: 15795593.
17. Saverymuttu SH, Peters AM, Crofton ME, Rees H, Lavender JP, Hodgson HJ, et al. 111Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut. 1985; 26(9):955-60. PMID: 4029721.
18. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000; 47(4):506-13. PMID: 10986210.
19. Li F, Ma J, Geng S, Wang J, Liu J, Zhang J, et al. Fecal calprotectin concentrations in healthy children aged 1-18 months. PLoS One. 2015; 10(3):e0119574.doi: 10.1371/journal.pone.0119574 PMID: 25742018.
20. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr. 2003; 37(4):468-72. PMID: 14508218.
21. Liu JR, Sheng XY, Hu YQ, Yu XG, Westcott JE, Miller LV, et al. Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth. BMC Pediatr. 2012; 12:129.doi: 10.1186/1471-2431-12-12 PMID: 22917269.
22. Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, et al. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: An observational study. BMC Gastroenterol. 2012; 12:5.doi: 10.1186/1471-230x-12-5 PMID: 22233279.
23. Ezri J, Nydegger A. Pediatrics. Fecal calprotectin in children: Use and interpretation. Rev Med Suisse. 2011; 7(277):69-70. PMID: 21309180.
24. Aomatsu T, Yoden A, Matsumoto K, Kimura E, Inoue K, Andoh A, et al. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease. Dig Dis Sci. 2011; 56 (8):2372-7.doi: 10.1007/s10620-011-1633-y PMID: 21394462.
25. Burri E, Beglinger C, von Felten S, Lehmann FS. Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis. Dig Dis Sci. 2015; 60(2):485-91.doi: 10.1007/s10620-014-3383-0 PMID: 25344905.
26. Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G. Fecal calprotectin in pediatric inflammatory bowel disease: A systematic review. Dig Dis Sci. 2013; 58(2):309-19.doi: 10.1007/s10620-012-2347-5 PMID: 22899243.
27. Dhaliwal J, Leach S, Katz T, Nahidi L, Pang T, Lee JM, et al. Intestinal inflammation and impact on growth in children with cystic fibrosis[J]. J Pediatr Gastroenterol Nutr. 2015, 60(4): 521-526.doi: 10. 1097/MPG.0000000000000683 PMID: 25539196
28. Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, et al. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases. Inflamm Bowel Dis. 2008; 14(9):1229-35.doi: 10.1002/ibd.20472 PMID: 18398894.
29. Oord T, Hornung N. Fecal calprotectin in healthy children. Scand J Clin Lab Invest. 2014; 74(3):254-8.doi: 10.3109/00365513.2013.879732 PMID: 24568692.
30. Hestvik E, Tumwine JK, Tylleskar T, Grahnquist L, Ndeezi G, Kaddu-Mulindwa DH, et al. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: A community-based survey. BMC Pediatr. 2011; 11:9.doi: 10.1186/1471-2431-11-9 PMID: 21284894.
31. Ma JQ, Zhou LL, Hu YQ, Liu SS, Sheng XY. Association between feeding practices and weight status in young children[J]. BMC Pediatr. 2015, 15:97. PMID: 26306490 doi: 10.1186/s12887-015-0418-4
32. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999; 45(3):362-6. PMID: 10446103.
33. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999; 34(1):50-4. PMID: 10048733.
34. Dumoulin EN, Van Biervliet S, Langlois MR, Delanghe JR. Proteolysis is a confounding factor in the interpretation of faecal calprotectin[J]. Clin Chem Lab Med. 2015, 53(1): 65-71. PMID: 24995405.doi: 10.1515/cclm-2014-0568
35. Kolho KL, Alfthan H, Hamalainen E. Effect of bowel cleansing for colonoscopy on fecal calprotectin levels in pediatric patients[J]. J Pediatr Gastroenterol Nutr. 2012, 55(6): 751-753.doi: 10.1097/MPG. 0b013e31825f4c77 PMID: 22614113